A European survey on remote monitoring of cardiac implantable electronic devices found that 91.4% of centres consider it best used in patients with implantable cardioverter-defibrillators.
Cross-Sectional
Yes
What is the current use, infrastructure, organization, patient selection, and benefits of remote monitoring for cardiac implantable electronic devices in Europe?
A European survey indicates that remote monitoring of cardiac implantable electronic devices reduces face-to-face visits, is frequently nurse-led, and is considered most beneficial for ICD patients and those living far from the hospital.
The aim of this European Heart Rhythm Association survey was to provide an insight into the current use of remote monitoring for cardiac implantable electronic devices in Europe. The following topics were explored: use of remote monitoring, infrastructure and organization, patient selection and benefits. Centres using remote monitoring reported performing face-to-face visits less frequently. In many centres (56.9%), a nurse reviews all the data and forwards them to the responsible physician. The majority of the centres (91.4%) stated that remote monitoring is best used in patients with implantable cardioverter-defibrillators and those live far from the hospital (76.6% top benefit). Supraventricular and ventricular arrhythmias were reported to be the major events detected earlier by remote monitoring. Remote monitoring will have a significant impact on device management.
Hernández‐Madrid et al. (Mon,) conducted a cross-sectional in Cardiac implantable electronic devices. Remote monitoring was evaluated on Current use, infrastructure, organization, patient selection and benefits of remote monitoring. A European survey on remote monitoring of cardiac implantable electronic devices found that 91.4% of centres consider it best used in patients with implantable cardioverter-defibrillators.